ArticleNature reviews. Clinical oncology2024

Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab.

Rafael Rosell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.